Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia
- PMID: 3153236
- DOI: 10.3109/08880018609031223
Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia
Abstract
Methotrexate (MTX) is an antifolate that inhibits cell division by reducing intracellular amounts of reduced tetrahydrofolates. Of 53 children with acute lymphoblastic leukemia (ALL) in maintenance treatment with MTX and 6-mercaptopurine (6-MP), 25 had received daily folic acid supplements in vitamin tablets containing 75-200 micrograms folic acid for at least the preceding 3-month period. Experimental data have shown that increased folate concentrations intracellularly inhibit MTX metabolism and toxicity. Therefore we found it relevant to investigate the extent to which folic acid supplements affect hematological tolerance to MTX and 6-MP in children during maintenance therapy for ALL. The erythrocyte folate (ery-folate) concentration was significantly higher in children who received extra folic acid than in those who did not (p less than 0.001). The ery-folate in MTX-treated children was only marginally reduced compared with the controls. The erythrocyte methotrexate (ery-MTX) concentration correlated with the weekly dose of MTX but not with any of the investigated hematological parameters. Children who received vitamin tablets containing folic acid had higher thrombocyte counts (p = 0.0056), higher leukocyte counts (p = 0.06), higher neutrophil counts (p = 0.05), and lower erythrocyte mean cell volumes (p = 0.05) than children who received no folic acid. We conclude that folic acid supplements of 75-200 micrograms/day affect the proliferative capacity of the bone marrow. Since none of the children was folate deficient as judged by the ery-folate, we recommend that vitamins given to children in maintenance treatment with MTX and 6-MP for ALL should not contain folic acid.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.Cancer Chemother Pharmacol. 2015 May;75(5):1089-93. doi: 10.1007/s00280-015-2717-8. Epub 2015 Mar 19. Cancer Chemother Pharmacol. 2015. PMID: 25788208
-
6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia.Leukemia. 2001 Jan;15(1):74-9. doi: 10.1038/sj.leu.2401986. Leukemia. 2001. PMID: 11243403 Clinical Trial.
-
The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).Gen Pharmacol. 1999 Oct;33(4):341-6. doi: 10.1016/s0306-3623(99)00022-1. Gen Pharmacol. 1999. PMID: 10523073 Review.
-
In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Clinical significance of methotrexate concentrations in erythrocytes.Dan Med Bull. 1990 Feb;37(1):22-40. Dan Med Bull. 1990. PMID: 2178886 Review.
-
Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.Pediatr Hematol Oncol. 1991 Oct-Dec;8(4):301-12. doi: 10.3109/08880019109028803. Pediatr Hematol Oncol. 1991. PMID: 1782110
Cited by
-
The safety of commonly used vitamins and minerals.Aust Prescr. 2021 Aug;44(4):119-123. doi: 10.18773/austprescr.2021.029. Epub 2021 Aug 2. Aust Prescr. 2021. PMID: 34421176 Free PMC article. Review.
-
Profile of anemia in acute lymphoblastic leukemia patients on maintenance therapy and the effect of micronutrient supplementation.Support Care Cancer. 2020 Feb;28(2):731-738. doi: 10.1007/s00520-019-04862-6. Epub 2019 May 27. Support Care Cancer. 2020. PMID: 31134344
-
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.J Pediatr Hematol Oncol. 2014 Oct;36(7):503-17. doi: 10.1097/MPH.0000000000000206. J Pediatr Hematol Oncol. 2014. PMID: 24936744 Free PMC article. Review.
-
Role of red blood cells in pharmacokinetics of chemotherapeutic agents.Clin Pharmacokinet. 2003;42(9):779-91. doi: 10.2165/00003088-200342090-00001. Clin Pharmacokinet. 2003. PMID: 12882586 Review.
-
Methotrexate in neutrophils in children with acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 1987;19(4):339-42. doi: 10.1007/BF00261485. Cancer Chemother Pharmacol. 1987. PMID: 3474084
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical